Allianz Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Buy |
22,300
+15,900
| +248% | +$879K | ﹤0.01% | 1220 |
|
|
2025
Q1 | $310K | Sell |
6,400
-4,600
| -42% | -$222K | ﹤0.01% | 1564 |
|
|
2024
Q4 | $425K | Sell |
11,000
-8,300
| -43% | -$320K | ﹤0.01% | 1454 |
|
|
2024
Q3 | $869K | Buy |
19,300
+8,200
| +74% | +$369K | ﹤0.01% | 1269 |
|
|
2024
Q2 | $385K | Hold |
11,100
| – | – | ﹤0.01% | 1473 |
|
|
2024
Q1 | $321K | Buy |
+11,100
| New | +$321K | ﹤0.01% | 1516 |
|
|
2023
Q2 | – | Sell |
-21,500
| Closed | -$495K | – | 1739 |
|
|
2023
Q1 | $495K | Hold |
21,500
| – | – | ﹤0.01% | 1431 |
|
|
2022
Q4 | $235K | Buy |
+21,500
| New | +$235K | ﹤0.01% | 1432 |
|
|
2022
Q3 | – | Sell |
-164,075
| Closed | -$1.3M | – | 1621 |
|
|
2022
Q2 | $1.3M | Buy |
164,075
+31,341
| +24% | +$248K | ﹤0.01% | 1419 |
|
|
2022
Q1 | $3.14M | Sell |
132,734
-2,059
| -2% | -$48.8K | ﹤0.01% | 1238 |
|
|
2021
Q4 | $4.61M | Buy |
134,793
+85,622
| +174% | +$2.93M | ﹤0.01% | 1149 |
|
|
2021
Q3 | $871K | Sell |
49,171
-25,089
| -34% | -$444K | ﹤0.01% | 1612 |
|
|
2021
Q2 | $3.33M | Hold |
74,260
| – | – | ﹤0.01% | 1151 |
|
|
2021
Q1 | $1.92M | Hold |
74,260
| – | – | ﹤0.01% | 1279 |
|
|
2020
Q4 | $1.5M | Hold |
74,260
| – | – | ﹤0.01% | 1366 |
|
|
2020
Q3 | $1.45M | Sell |
74,260
-1,530
| -2% | -$29.9K | ﹤0.01% | 1327 |
|
|
2020
Q2 | $1.34M | Sell |
75,790
-26,308
| -26% | -$464K | ﹤0.01% | 1362 |
|
|
2020
Q1 | $720K | Buy |
102,098
+30,097
| +42% | +$212K | ﹤0.01% | 1535 |
|
|
2019
Q4 | $507K | Sell |
72,001
-41,275
| -36% | -$291K | ﹤0.01% | 1918 |
|
|
2019
Q3 | $1.39M | Sell |
113,276
-10,814
| -9% | -$132K | ﹤0.01% | 1581 |
|
|
2019
Q2 | $1.5M | Buy |
124,090
+47,175
| +61% | +$571K | ﹤0.01% | 1639 |
|
|
2019
Q1 | $967K | Buy |
+76,915
| New | +$967K | ﹤0.01% | 1771 |
|